Technical resources
Is a falling peptide signal caused by the autosampler wait?
A declining injection series can mix sample residence time with instrument order. Design an interleaved comparison using independently aged aliquots, fresh preparations and blanks to identify which explanation deserves further testing before changing the peptide sample.
Twelve peptide samples enter an autosampler together and are injected one after another. Their responses decline. The last sample has both waited longest and run latest, so the sequence alone cannot distinguish a sample-time effect from an instrument-order effect. Build the next run to separate those variables.
Define two clocks
Record time since preparation and time since loading into the final container. These may differ when samples spend time in an intermediate tube. Keep acquisition time as a third field. Use actual timestamps rather than scheduled positions when delays or aborted injections change the sequence.
The existing solubility and recovery guide discusses the starting sample. Here the question is narrower: whether the measured response changes during the analytical queue under the conditions actually used.
Separate age from injection order
Prepare independent aliquots intended for different residence intervals. Interleave fresh comparison preparations so that late injections include both older and recently prepared samples. The laboratory should choose intervals reflecting its real queue and confirm that the preparation itself is reproducible.
Keep the analysis order varied within practical blocks. NIST’s randomized-block guidance explains how blocking can account for nuisance variation while comparing the factor of interest. For this proposed investigation, a block might be a short sequence containing old and fresh preparations measured close together.
Avoid assuming repeated injections from one vial are equivalent to independent aged aliquots. Repeated sampling changes the vial’s history. Use that arrangement only when it represents the routine procedure being assessed, and identify it separately in the worksheet.
Include a check sample and carryover blanks
Place an appropriate instrument check sample throughout the run. Its purpose is to show whether the measurement system changes during the sequence. Keep its own handling consistent, and do not assume it behaves like the target peptide merely because both are measured by LC-MS.
Include blanks after relevant samples. A neuropeptide Y carryover study investigated different parts of the LC-MS system and showed method-dependent carryover behavior. Its results support examining the analytical path; they do not prescribe a universal wash solvent or column for other peptides.
Read the patterns together
If aged aliquots decline while nearby fresh preparations and the check sample remain consistent, investigate the sample’s residence conditions. If fresh and aged preparations move together with acquisition order, investigate the measurement system. A positive post-sample blank adds a carryover question that needs its own follow-up.
Keep absolute analyte response, internal-standard response and their ratio in the report. Show each preparation separately before averaging. Where sample chemistry is suspected, ask for suitable identity or related-species information; a response decrease alone does not establish chemical degradation.
Turn the result into a queue rule
After identifying a workable preparation and residence interval, confirm it in a realistic sequence with the expected concentration range and sample matrix. Define what happens when an interruption extends the wait beyond the tested interval. Repreparation or additional review may be appropriate, but the action must follow the method’s evidence.
Document the exact container, volume and queue conditions supporting the rule. Call it a tested analytical hold interval, with its scope, rather than converting it into a general shelf-life statement. Preserve failed runs when they explain why a later queue arrangement was selected.
Questions and answers
Why is a simple first-to-last injection plot inconclusive?
Sample age and injection order often increase together. The plot shows an association but cannot isolate either factor. Interleave preparations with different ages to make the next comparison more informative.
Should every time point come from the same vial?
Use the same vial when evaluating that exact repeated-injection workflow. Use separate aliquots when independent residence periods are the question, and preserve the distinction in analysis.
Can an unchanged instrument check rule out sample-specific suppression?
No. A check prepared in a different matrix or containing another analyte may not experience the same interference. It helps assess the system within its demonstrated scope.
Does a decreasing peak prove the peptide degraded?
No. Adsorption, changing analytical response and other losses remain possible. Investigate chemical identity or related species with a suitable method before assigning degradation as the cause.
Can the tested queue interval become the product's shelf life?
No. It applies to the analytical preparation and conditions studied. Product shelf life is a separate question requiring evidence for the supplied material and its relevant storage configuration.